Home › Funds › STEMPOINT CAPITAL LP › SRZN
STEMPOINT CAPITAL LP position in SRZN
SURROZEN INC · Health Care
STEMPOINT CAPITAL LP reported holding 602,798 shares of SRZN (SURROZEN INC) in its Q2 2026 13F filing — a position valued at US$13.8M, representing 3.05% of its reported portfolio and ranking #6 among its reported holdings. STEMPOINT CAPITAL LP has disclosed SRZN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's SRZN position evolved
STEMPOINT CAPITAL LP first disclosed a stake in SRZN in Q2 2024 at 143,510 shares (US$1.6M). The position peaked in Q2 2026 at 602,798 shares, worth US$13.8M. Across 9 filings, STEMPOINT CAPITAL LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 602,798 shares valued at US$13.8M — an increase of 77,159 shares quarter over quarter.. Notable position changes include a 92% increase in Q4 2024 (shares fell 19% over the following quarter), a 31% trim in Q1 2025 (shares fell 23% over the following quarter), a 185% increase in Q2 2025 (shares rose 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 143.51K | $1.57M | New |
| Q3 2024 | 182.92K | $2.19M | Add |
| Q4 2024 | 350.57K | $5.03M | Add |
| Q1 2025 | 240.83K | $2.81M | Reduce |
| Q2 2025 | 686.54K | $6.14M | Add |
| Q3 2025 | 713.46K | $9.19M | Add |
| Q4 2025 | 619.77K | $12.67M | Reduce |
| Q1 2026 | 525.64K | $13.46M | Reduce |
| Q2 2026 | 602.80K | $13.79M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRZN and 13F data
SRZN (SURROZEN INC) is a Health Care company. 51 other funds we track also report a position in SRZN — the largest reported positions include Column Group LLC (US$49.7M), TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRZN
- Column Group LLC 1.92M sh · $49.74M · Q2 2026
- TCG Crossover Management, LLC 1.47M sh · $38.23M · Q2 2026
- Boxer Capital Management, LLC 1.11M sh · $26.96M · Q2 2026
- Venrock Adviser, LLC 632.93K sh · $16.42M · Q2 2026
- Spruce Street Capital LP 432.04K sh · $11.21M · Q2 2026
- Kalehua Capital Management LLC 385.18K sh · $10.00M · Q2 2026
- 5AM Venture Management, LLC 271.25K sh · $7.04M · Q2 2026
- Vivo Capital, LLC 260.00K sh · $6.75M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 173.40K sh · $4.50M · Q2 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K sh · $3.46M · Q2 2026
- Euclidean Capital LLC 87.70K sh · $2.28M · Q2 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held SRZN?
STEMPOINT CAPITAL LP has disclosed SRZN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is STEMPOINT CAPITAL LP's current position in SRZN?
As of Q2 2026, STEMPOINT CAPITAL LP holds 602.80K shares of SRZN (SURROZEN INC), valued at $13.79M, representing 3.05% of its reported portfolio and ranking #6.
Has STEMPOINT CAPITAL LP been buying or selling SRZN?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP increased its position in SRZN. The position peaked in Q2 2026 at 602.80K shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include Column Group LLC, TCG Crossover Management, LLC, Boxer Capital Management, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.